Clinical Trials Logo

Clinical Trial Summary

Objective:

Due to high mortality rates the capillary leakage and the acute abdomen are important risk factors of the probability of survival. The aim of an optimal therapy of the acute abdomen within the neonatal period is beside the cure of the underlying disease the prophylaxis of capillary leakage with the help of optimised intra- and postoperative volume therapy.

Question:

Do the neonates with very low birth weight and a surgery therapy of acute abdomen benefit from early increase of the haemoglobin/haematocrit by optimised volume therapy with crystalloid and colloidal volume as prophylaxis of the capillary leakage?


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01817062
Study type Observational
Source Charite University, Berlin, Germany
Contact
Status Completed
Phase N/A
Start date January 2001
Completion date March 2013

See also
  Status Clinical Trial Phase
Completed NCT02447250 - Preterm Infant Inhaled Albuterol Dosing Phase 4
Completed NCT00593684 - The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants N/A